Literature DB >> 15889353

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

Samir K Gupta1, Joseph A Eustace, Jonathan A Winston, Ivy I Boydstun, Tejinder S Ahuja, Rudolph A Rodriguez, Karen T Tashima, Michelle Roland, Nora Franceschini, Frank J Palella, Jeffrey L Lennox, Paul E Klotman, Sharon A Nachman, Stephen D Hall, Lynda A Szczech.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15889353     DOI： 10.1086/430257

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  165 in total

1.  The morbidity and mortality associated with kidney disease in an HIV-infected cohort in Puerto Rico.

Authors:  Angel M Mayor; Mark Dworkin; Luis Quesada; Eddy Ríos-Olivares; Robert F Hunter-Mellado
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

2.  Familial collapsing focal segmental glomerulosclerosis.

Authors:  V Liakopoulos; A Huerta; S Cohen; M R Pollak; R A Sirota; K Superdock; G B Appel
Journal:  Clin Nephrol       Date:  2011-04       Impact factor: 0.975

3.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

4.  Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.

Authors:  Alonso Heredia; Olga Latinovic; Robert C Gallo; Gregory Melikyan; Marv Reitz; Nhut Le; Robert R Redfield
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

5.  Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Authors:  Alison G Abraham; Annie Darilay; Heather McKay; Joseph B Margolick; Michelle M Estrella; Frank J Palella; Robert Bolan; Charles R Rinaldo; Lisa P Jacobson
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

Review 6.  The treatment of HIV-associated nephropathy.

Authors:  Robert C Kalayjian
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

Review 7.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

8.  Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.

Authors:  Clara Y Jones; Camille A Jones; Ira B Wilson; Tamsin A Knox; Andrew S Levey; Donna Spiegelman; Sherwood L Gorbach; Frederick Van Lente; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2008-05-02       Impact factor: 8.860

Review 9.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.